Navigation Links
Immunoglobulin Market (PI & CIDP ) Analysis and Forecasts to 2019 in New Research Report at ReportsnReports.com
Date:5/27/2013

Dallas, Texas (PRWEB) May 27, 2013

“Immunoglobulins Market to 2019 Demand in Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Potentially Supplemented by Approvals for Alzheimer’s Disease” provides in-depth analysis of the global immunoglobulin market. The report analyzes the markets for immunoglobulin products in the US, the top five European countries (the UK, Germany, France, Italy and Spain) and Japan. The revenue and annual cost of therapy are forecast for the key geographies and in seven key therapeutic segments, along with epidemiological data, until 2019. The seven key therapeutic segments are Primary Immunodeficiency (PI), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Multifocal Motor Neuropathy (MMN), Guillain-Barré Syndrome (GBS), Myasthenia Gravis (MG), Idiopathic Thrombocytopenic Purpura (ITP), and Chronic Lymphocytic Leukemia (CLL). The report (http://www.reportsnreports.com/reports/239437-immunoglobulins-market-to-2019-demand-in-primary-immunodeficiency-pi-and-chronic-inflammatory-demyelinating-polyneuropathy-cidp-potentially-supplemented-by-approvals-for-alzheimers-disease.html) also profiles the marketed products, key pipeline products, and leading companies that could change the market landscape in the forecast period.

The report expects the immunoglobulin market to see a slight increase in its growth rate during the 2012–2019 forecast period. It was worth $3.6 billion in 2012, having grown at a Compound Annual Growth Rate (CAGR) of 6% from 2006. Demand for immunoglobulin products continues to increase due to growing disease awareness and therapeutic usage in a wide range of therapeutic areas. Immunology and neurology are the disciplines that use the most immunoglobulins, while PI and CIDP are the top indications. Geographically, the US is the largest market, commanding a share of over 70% of the global market. 11 new products have been approved in the US since 2006, but as many are for PI or ITP, immunoglobulin usage in the US remains off-label for all other indications.

Baxter, CSL Behring, and Grifols continue to command the top ranks in terms of revenue, and recent approvals of Subcutaneous Immunoglobulins (SCIGs) in the US and Europe will further boost market growth.

Scope

  •     Annualized market data for the immunoglobulin market from 2006 to 2012 and forecast to 2019
  •     Analysis of the seven key therapeutic segments: PI, CIDP, MMN, MG, CLL, GBS and ITP
  •     Analysis of the immunoglobulins markets in the leading global geographies: the US, the top five European countries, and Japan
  •     Market characterization of the immunoglobulin market, covering size, revenue analysis by geography, the annual cost of therapy, and epidemiology
  •     Key drivers and barriers that have a significant impact on the market
  •     Coverage of key marketed products, approved indications, and safety and efficacy profiles
  •     Coverage of the pipeline molecules in various phases of drug development
  •     Competitive profiling of the leading companies: Baxter, Biotest, Bio Products Laboratory, CSL Behring, Grifols, and Octapharma
  •     Key M&A activity and licensing agreements between 2012 and mid-2013 in the global immunoglobulin market
  •     Overview of the immunoglobulin markets in Asia-Pacific and China, covering regulations, key players and marketed products

Reasons To Buy

  •     Align your product portfolio to the markets with high growth potential
  •     Develop market-entry and market-expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth
  •     Develop key strategic initiatives by understanding the key focus areas of the leading companies
  •     Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps

Buy a copy of report @ http://www.reportsnreports.com/purchase.aspx?name=239437.

Immunoglobulins Market to 2019 - Profiles of Marketed Products:
1.    Privigen
2.    Gammagard S/D
3.    Gammagard Liquid
4.    Octagam 5%
5.    Flebogamma 10% DIF
6.    Gamunex-C
7.    Gammaplex
8.    HyQvia
9.    Bivigam

Explore more reports on Pharmaceuticals Market @ http://www.reportsnreports.com/market-research/pharmaceuticals/.

About US:
ReportsnReports.com (http://www.reportsnreports.com/) is an online market research reports library of 200,000+ reports and in-depth studies of 5000+ micro markets. Our database includes reports by leading publishers from across the globe.

Read the full story at http://www.prweb.com/releases/immunoglobulin-market/pi-cidp-analysis-2019/prweb10772086.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency And CIDP Potentially Supplemented by Approval for Alzheimers Disease Available at ResearchMoz.us
2. Majority of states fail to address youth exposure to alcohol marketing
3. Article Marketing Company Content Writing King Announces Training Of New Graphic Design Artist
4. Beef & Pork Wholesaling in the US Industry Market Research Report Now Available from IBISWorld
5. New Report Video Surveillance Market (2011 – 2016) by MarketsandMarkets
6. Dotcomsecrets is Offering New Opportunities to People Who Want to Become Expert in Localized Internet Marketing
7. 101 Mobility Opens Franchise in Roanoke/Lynchburg Market
8. How MyTownInsurance.com Helps Insurance Carriers Manage their Loss Exposure through On-Line Marketing
9. Discount Supermarkets Tied to Rising Obesity Rates
10. DotComSecrets Invites Professionals to Learn Great Tips On How to Make a Handsome Income By Working As Local Internet Marketing Consultants
11. Heavy Duty Alternators and Starters Expert Elreg Distributors Ltd. Meets Needs of International Market with Launch of Spanish Website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... 29, 2016 , ... Conditions were ideal for Global Lyme Alliance’s (GLA) 2nd ... sunny skies, a light breeze and temperatures in the 60s. Over 400 runners, walkers ... and Walk and 1-mile walk were held to increase awareness about Lyme disease ...
(Date:4/29/2016)... ... 2016 , ... Spine Team Texas, a comprehensive spine physician group specializing in ... physicians has been invited to be a featured speaker at the Texas Society of ... April 30, 2016. , Dr. R. Scott McPherson, a physical medicine and rehabilitation ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... announces the Gyrociser, an exercise invention which aids in proper muscle development. , ... Cooper, CEO and Creative Director of World Patent Marketing. "Globalization has threatened the ...
(Date:4/29/2016)... ... April 29, 2016 , ... Dr. Robert Mondavi, one of ... improve smiles. Cosmetic dentistry is a fast-growing field as more patients are discovering the ... to learn more about the options currently available to them and which ones might ...
(Date:4/29/2016)... ... , ... For those who skip meals occasionally (which is pretty much everyone), ... many new lifestyle diet tips offered by nutritionists Pam Bonney and Priya Lawrence of ... show. Bonny and Lawrence noted that because proper nutrition, including water, provides energy during ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 28, 2016  While Abbott,s announced purchase of ... valve repair and stent business, healthcare research firm ... more firmly into patient monitoring.  Kalorama said that ... device areas, with double-digit growth expected the next ... Advanced Remote Patient Monitoring . Abbott Laboratories ...
(Date:4/28/2016)... 28, 2016 Treato , ... healthcare, announced today that it has been named a ... Vendor in Life Sciences, 2016, Stephen Davies ... report focuses on life-science- oriented analytics, algorithms and smart ... and doctors, confirm medication ingestion, and analyze unstructured information. ...
(Date:4/28/2016)... 2016  ValGenesis, Inc., the market leader ... today announced that a prominent world provider ... chronic kidney failure has selected ValGenesis Validation ... validation process. The global medical device manufacturer ... manage their validation processes electronically. Upon completion ...
Breaking Medicine Technology: